Schedule 13D ownership disclosure

UROGEN PHARMA LTD

Ordinary Shares, par value NIS 0.01 per share · CUSIP: M96088105

Event date: 2025-06-05

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Monograph Capital Partners I, L.P.Reported CIK 0001864082

    Shares: 838,615.00 · Class: 1.8%

  • Monograph Capital Partners I GenPar, LP

    Shares: 838,615.00 · Class: 1.8%

  • Monograph Capital Holdings Advisors, LLCReported CIK 0001988760

    Shares: 838,615.00 · Class: 1.8%

  • Fred CohenReported CIK 0001339358

    Shares: 838,615.00 · Class: 1.9%

  • Charles Conn

    Shares: 838,615.00 · Class: 1.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-25-007493
Form type
SCHEDULE 13D/A
Filer
Monograph Capital Holdings Advisors, LLC
CIK
CIK 1988760
Filed
Jun 09, 2025
Reporting period
Jun 05, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub